DATA
Data di pubblicazione: 29/03/2011
AUTORI
DIAS-SANTAGATA DORA
LAM QUYNH
VERNOVSKY KATHY
VENA NATALIE
LENNERZ JOCHEN K
BORGER DARRELL R
BATCHELOR TRACY T
LIGON KEITH L
IAFRATE A JOHN
LIGON AZRA H
LOUIS DAVID N
SANTAGATA SANDRO
ENTE DI AFFERENZA
Department of Medical Oncology Dana–Farber Cancer Institute Boston Massachusetts United States of America
Center for Molecular Oncologic Pathology Dana–Farber Cancer Institute Boston Massachusetts United States of America
DEPT PATHOLOGY & CTR CANCER RSCH MASSACHUSETTS GEN HOSPITAL & HARVARD MEDICAL SCHOOL BOSTON MASSACHUSETTS USA
HEMATOLOGY ONCOLOGY MASSACHUSETTS GEN HOSPITAL CANCER CTR & HARVARD MEDICAL SCHOOL BOSTON MASSACHUSETTS USA
DEPT NEUROLOGY & DEPT RADIATION ONCOLOGY MASSACHUSETTS GEN HOSPITAL BOSTON MASSACHUSETTS USA
DEPT PATHOLOGY CHILDRENS HOSPITAL BOSTON & HARVARD MEDICAL SCHOOL BOSTON MASSACHUSETTS USA
DEPT PATHOLOGY BRIGHAM & WOMENS HOSPITAL & HARVARD MEDICAL SCHOOL BOSTON MASSACHUSETTS USA
STANFORD UNIV SCHOOL OF MEDICINE USA
RIVISTA
PLoS ONE, 6(3), e17948
IMPACT FACTOR
2,870